Loading organizations...
Loading organizations...
Develops curative and regenerative medicines using stem cell technology.
AIVITA Biomedical has raised $43.7M across 4 funding rounds.
AIVITA Biomedical has raised $43.7M in total across 4 funding rounds.
AIVITA Biomedical has raised $43.7M in total across 4 funding rounds.
AIVITA Biomedical's investors include Matthew Katz, California Institute for Regenerative Medicine, SFC Capital, Alexander Suh.
AIVITA Biomedical has raised $43.7M across 4 funding rounds. Most recently, it raised $25.0M Series B in February 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 25, 2020 | $25.0M Series B | Matthew Katz | |
| Jul 18, 2018 | $1.7M Other Equity | California Institute for Regenerative Medicine | |
| Jun 12, 2018 | $15.0M Series B | SFC Capital | |
| Jun 11, 2016 | $2.0M Series A | Alexander Suh |